Schonfeld Strategic Advisors LLC Xenon Pharmaceuticals Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 13,582 shares of XENE stock, worth $534,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,582
Previous 32,260 57.9%
Holding current value
$534,315
Previous $1.26 Million 57.52%
% of portfolio
0.0%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$36.12 - $43.96 $674,649 - $821,084
-18,678 Reduced 57.9%
13,582 $534,000
Q2 2024

Aug 14, 2024
SELL
$36.25 - $43.75 $1.73 Million - $2.09 Million
-47,691 Reduced 59.65%
32,260 $1.26 Million
Q1 2024

May 15, 2024
SELL
$42.66 - $50.04 $322,040 - $377,751
-7,549 Reduced 8.63%
79,951 $3.44 Million
Q4 2023

Feb 14, 2024
SELL
$28.7 - $46.46 $3.2 Million - $5.18 Million
-111,484 Reduced 56.03%
87,500 $4.03 Million
Q3 2023

Nov 14, 2023
BUY
$34.16 - $39.73 $643,608 - $748,552
18,841 Added 10.46%
198,984 $6.8 Million
Q2 2023

Aug 14, 2023
SELL
$34.84 - $43.54 $4.18 Million - $5.22 Million
-119,976 Reduced 39.98%
180,143 $6.94 Million
Q1 2023

May 15, 2023
BUY
$33.46 - $40.35 $4.41 Million - $5.31 Million
131,706 Added 78.2%
300,119 $10.7 Million
Q4 2022

Feb 14, 2023
BUY
$33.06 - $39.43 $1.99 Million - $2.37 Million
60,129 Added 55.53%
168,413 $6.64 Million
Q3 2022

Nov 14, 2022
SELL
$30.79 - $39.82 $610,411 - $789,431
-19,825 Reduced 15.48%
108,284 $3.91 Million
Q2 2022

Aug 15, 2022
BUY
$25.44 - $35.16 $654,698 - $904,842
25,735 Added 25.14%
128,109 $3.9 Million
Q1 2022

May 16, 2022
BUY
$25.09 - $33.13 $338,062 - $446,393
13,474 Added 15.16%
102,374 $3.13 Million
Q4 2021

Feb 14, 2022
SELL
$15.6 - $35.4 $487,047 - $1.11 Million
-31,221 Reduced 25.99%
88,900 $2.78 Million
Q3 2021

Nov 16, 2021
BUY
$14.86 - $19.45 $349,522 - $457,483
23,521 Added 24.35%
120,121 $1.84 Million
Q2 2021

Aug 16, 2021
BUY
$16.81 - $20.0 $221,891 - $264,000
13,200 Added 15.83%
96,600 $1.8 Million
Q1 2021

May 17, 2021
BUY
$13.65 - $21.31 $147,420 - $230,148
10,800 Added 14.88%
83,400 $1.49 Million
Q4 2020

Feb 16, 2021
BUY
$9.49 - $16.04 $94,900 - $160,400
10,000 Added 15.97%
72,600 $1.12 Million
Q3 2020

Nov 16, 2020
BUY
$10.82 - $13.35 $292,140 - $360,450
27,000 Added 75.84%
62,600 $1,000
Q2 2020

Aug 14, 2020
BUY
$10.21 - $14.9 $230,746 - $336,740
22,600 Added 173.85%
35,600 $447,000
Q1 2020

May 15, 2020
SELL
$8.08 - $17.57 $455,712 - $990,948
-56,400 Reduced 81.27%
13,000 $147,000
Q4 2019

Feb 14, 2020
BUY
$8.11 - $14.65 $562,834 - $1.02 Million
69,400 New
69,400 $910,000
Q2 2019

Aug 14, 2019
SELL
$8.51 - $10.75 $4.26 Million - $5.38 Million
-500,000 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$6.39 - $10.42 $63,529 - $103,595
9,942 Added 2.03%
500,000 $5.08 Million
Q4 2018

Feb 14, 2019
SELL
$5.61 - $12.62 $405,911 - $913,120
-72,355 Reduced 12.87%
490,058 $3.09 Million
Q3 2018

Nov 14, 2018
BUY
$9.0 - $14.9 $966,717 - $1.6 Million
107,413 Added 23.61%
562,413 $7.42 Million
Q2 2018

Aug 14, 2018
BUY
$4.8 - $9.2 $336,000 - $644,000
70,000 Added 18.18%
455,000 $4.19 Million
Q4 2017

Feb 14, 2018
BUY
$2.2 - $3.25 $242,000 - $357,500
110,000 Added 40.0%
385,000 $1.09 Million
Q3 2017

Nov 14, 2017
BUY
$2.45 - $3.25 $673,750 - $893,750
275,000
275,000 $811,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.45B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email